{{Rsnum
|rsid=2581
|Gene=HLA-DOA
|Chromosome=6
|position=33006624
|Orientation=minus
|GMAF=0.4118
|Gene_s=HLA-DOA
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 25.7 | 38.1 | 36.3
| HCB | 28.5 | 51.8 | 19.7
| JPT | 10.6 | 42.5 | 46.9
| YRI | 8.8 | 39.5 | 51.7
| ASW | 14.0 | 36.8 | 49.1
| CHB | 28.5 | 51.8 | 19.7
| CHD | 38.5 | 48.6 | 12.8
| GIH | 19.8 | 41.6 | 38.6
| LWK | 7.3 | 46.4 | 46.4
| MEX | 10.3 | 44.8 | 44.8
| MKK | 12.8 | 49.4 | 37.8
| TSI | 17.6 | 46.1 | 36.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=23582631
|Title=Pathway analysis of genome-wide association studies on rheumatoid arthritis
}}

{{PMID Auto
|PMID=12830434
|Title=BRD2 (RING3) is a probable major susceptibility gene for common juvenile myoclonic epilepsy.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}